VISHEE(SH:688580) Zheng Quan Zhi Xing·2025-07-15 14:11Core Viewpoint - Nanjing Weisi Medical Technology Co., Ltd. has announced the completion of the "Research and Development Center Construction Project," which has reached the predetermined usable status, allowing the company to conclude this fundraising project [1][8]. Fundraising Overview - The company raised a total of RMB 1,154,716,955.86 through the public offering of 17,086,667 shares at a price of RMB 67.58 per share, with a net amount of RMB 1,062,986,960.68 after deducting issuance costs [1][2]. Investment Project Status - The "Research and Development Center Construction Project" has been completed, and the company has decided to conclude this project as it meets the completion criteria. The total investment amount for this project has been fully utilized [7][8]. - The project has experienced delays in the investment pace due to external environmental changes, leading to a postponement of the expected usable status date from September 2023 to December 2025 for both the "Research and Development Center Construction Project" and the "Information Technology Construction Project" [4][5]. Financial Details - The total investment amount for the "Research and Development Center Construction Project" is approximately RMB 1.25 billion, with a total area of nearly 24,000 square meters and a planned total investment of about RMB 500 million [4][5]. - The project has generated interest income, resulting in a cumulative investment amount exceeding 100% of the committed fundraising [7][8]. Approval Process - The conclusion of the fundraising project does not require board approval or consent from the supervisory board, as the remaining funds (including interest income) are below RMB 10 million [7][8].